微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 38.98% | -2.38% | -1.12% | 94/157 | 50.55% | 泽璟制药 | 94.64% | 行业排名> |
| 2025-12-31 | 39.42% | -23.65% | -3.42% | 92/157 | 50.61% | 海创药业 | 99.82% | 行业排名> |
| 2025-09-30 | 40.81% | -20.34% | -1.01% | 90/157 | -2.2% | 海创药业 | 98.62% | 行业排名> |
| 2025-06-30 | 41.23% | -15.76% | 3.27% | 90/157 | 14.83% | 海创药业 | 99.57% | 行业排名> |
| 2025-03-31 | 39.93% | -12.15% | -22.67% | 92/157 | 31.96% | 海创药业 | 99.52% | 行业排名> |
| 2024-12-31 | 51.63% | -7.63% | 0.77% | 76/157 | 51.88% | 艾力斯 | 96.74% | 行业排名> |
| 2024-09-30 | 51.24% | 1.23% | 4.68% | 74/157 | 22.51% | 首药控股 | 98.96% | 行业排名> |
| 2024-06-30 | 48.95% | -10.95% | 7.69% | 79/157 | 33.12% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-03-31 | 45.45% | -19.19% | -18.68% | 85/157 | 51.76% | 百利天恒 | 97.99% | 行业排名> |
| 2023-12-31 | 55.89% | -21.53% | 10.43% | 67/157 | 51.61% | 百利天恒 | 98.92% | 行业排名> |
| 2023-09-30 | 50.61% | -31.19% | -7.92% | 74/157 | 32.47% | 迈威生物 | 98.93% | 行业排名> |
| 2023-06-30 | 54.96% | -24.31% | -2.27% | 67/157 | 38.42% | 迈威生物 | 99.59% | 行业排名> |
| 2023-03-31 | 56.24% | -27.56% | -21.04% | 63/157 | 52.97% | 迈威生物 | 99.8% | 行业排名> |
| 2022-12-31 | 71.23% | -8.83% | -3.16% | 37/157 | 53.83% | 迈威生物 | 99.46% | 行业排名> |
| 2022-09-30 | 73.55% | 2% | 1.28% | 35/157 | 5.64% | 迈威生物 | 99.75% | 行业排名> |
| 2022-06-30 | 72.62% | -12.27% | -6.47% | 37/157 | 20.99% | 迈威生物 | 99.67% | 行业排名> |
| 2022-03-31 | 77.64% | 2% | -0.62% | 27/157 | 54.39% | 迈威生物 | 99.44% | 行业排名> |
| 2021-12-31 | 78.13% | -4.16% | -5.61% | 29/157 | 55.2% | 迈威生物 | 98.57% | 行业排名> |
| 2021-06-30 | 82.77% | 2% | 1.54% | 19/157 | 47.23% | 首药控股 | 99.93% | 行业排名> |
| 2020-12-31 | 81.52% | 31.38% | 31.38% | 20/157 | -148.64% | 艾力斯 | 99.41% | 行业排名> |
| 2019-12-31 | 62.05% | 23.55% | 23.55% | 53/157 | -1242.15% | 艾力斯 | 98.7% | 行业排名> |
| 2018-12-31 | 50.22% | 2% | 2% | 69/157 | -211.97% | 艾力斯 | 99.4% | 行业排名> |